recombinant tissue plasminogen activator: Clinical Trials

15 trials of recombinant tissue plasminogen activator, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 withdrawn, 1 recruiting, 1 unknown. 5 Phase 2, 4 Phase 3, 3 Phase 4, 2 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Unknown 1, Withdrawn 1
Phase 34Completed 3, Withdrawn 1
Phase 43Completed 3
Phase 12Completed 2
Early Phase 11Recruiting 1

Follow recombinant tissue plasminogen activator: new trials by email Literature Review of recombinant tissue plasminogen activator trials Research Report on recombinant tissue plasminogen activator

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
Alteplase, Placebo Administration - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Early Phase 1RecruitingM.D. Anderson Cancer Center302023-08-172026-08-17
Direct Mechanical Thrombectomy Versus Bridging Therapy
Trevo and or Merci devices for stent retreival, Penumbra system for stent aspiration, recombinant tissue plasminogen activator - Thrombectomy, Ischemic Stroke
Phase 4CompletedAlexandria University512019-07-012022-01-03
Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Recombinant tissue plasminogen activator (rt-PA), Standard Anticoagulation Therapy - Deep Vein Thrombosis, Post-Thrombotic Syndrome
Phase 3WithdrawnUniversity of Colorado, Denver2018-07-012018-08-10
Thrombolysis Endovascular Treatment of Pulmonary Embolism
recombinant tissue plasminogen activator - Pulmonary Embolism, Acute Pulmonary Embolism
Phase 3CompletedBeijing Tsinghua Chang Gung Hospital502017-01-012020-11-30
Thrombolysis Outcome in Ischemic Stroke
Alteplase - Stroke, Acute, Thrombolytic Therapy
CompletedMazandaran University of Medical Sciences2142017-01-012020-07-09
Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
Ekosonic® Endovascular Device ultrasonic infusion catheter, Recombinant tissue plasminogen activator - Pulmonary Embolism and Thrombosis
Phase 4CompletedBoston Scientific Corporation1312015-06-122021-07-19
Dose-effect Relationship of Rt-PA on ICH Evacuation
YL-1 type of intracranial hematoma puncture needle, rt-PA - Hypertensive Intracerebral Hemorrhage
Phase 2UnknownTongji Hospital1082015-06-012015-06-16
Sonothrombolysis Potentiated by Microbubbles for Acute Ischemic Stroke
Sulfur hexafluoride + ultrasounds, Recombinant tissue plasminogen activator - Cerebrovascular Stroke
Phase 2CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau242012-08-012015-08-10
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
recombinant tissue plasminogen activator, EKOS EkoSonic Endovascular System - Pulmonary Embolism, Acute Pulmonary Embolism
Phase 3CompletedBoston Scientific Corporation1502012-06-072021-07-19
Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke
Penumbra™ System, Recombinant tissue plasminogen activator - Stroke
Phase 2WithdrawnHospital de Clinicas de Porto Alegre2010-05-012015-09-03
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Recombinant tissue plasminogen activator (rt-PA) - Deep Vein Thrombosis, Venous Thrombosis
Phase 3CompletedWashington University School of Medicine6922009-11-012018-03-29
In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer
recombinant tissue plasminogen activator, captopril - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1 / Phase 2CompletedNorthwestern University2003-07-012012-06-11
Interventional Management of Stroke (IMS) II Study
Recombinant tissue plasminogen activator, Low-intensity ultrasound - Stroke
Phase 2CompletedUniversity of Cincinnati812003-01-012012-07-25
Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China
rt-PA - Pulmonary Embolism, Thromboembolism
Phase 4CompletedBeijing Chao Yang Hospital1182002-06-012008-10-29
Treatment for Blood Clots in the Veins of the Legs
Recombinant Tissue Plasminogen Activator, Heparin, Warfarin - Embolism, Thrombophlebitis
Phase 1CompletedNational Institutes of Health Clinical Center (CC)201998-02-012008-03-04

Conditions studied

Pulmonary Embolism (4)  ·  Stroke (4)  ·  Thrombosis (4)  ·  Embolism (2)  ·  Ischemic Stroke (2)  ·  Postthrombotic Syndrome (2)  ·  Venous Thrombosis (2)  ·  Cerebral Hemorrhage (1)  ·  Hematologic Neoplasms (1)  ·  Intracranial Hemorrhage, Hypertensive (1)  ·  Postphlebitic Syndrome (1)  ·  Thromboembolism (1)  ·  Thrombophlebitis (1)  ·  Venous Thromboembolism (1)

Sponsors

Boston Scientific Corporation (2)  ·  Alexandria University (1)  ·  Beijing Chao Yang Hospital (1)  ·  Beijing Tsinghua Chang Gung Hospital (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mazandaran University of Medical Sciences (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  Northwestern University (1)  ·  Tongji Hospital (1)  ·  University of Cincinnati (1)  ·  University of Colorado, Denver (1)  ·  Washington University School of Medicine (1)

Countries

United States (7)  ·  China (3)  ·  Brazil (1)  ·  Egypt (1)  ·  Iran (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Barry S Weinstock, MD (1)  ·  Clive Kearon, MB, MRCP, FRCP(C), PhD (1)  ·  Fakhir Elmasri, MD (1)  ·  Horiana Grosu, M D (1)  ·  Immad Sidiq, MD (1)  ·  Jacob Cynamon, MD (1)  ·  John Gurley, MD (1)  ·  John Rundback, MD (1)  ·  Joseph P. Broderick, MD (1)  ·  Juan Ayerdi, MD (1)  ·  Kannan Natarajan, MD (1)  ·  Keith M Sterling, MD (1)  ·  Marilyn J Manco-Johnson, MD (1)  ·  Mark J Garcia, MD (1)

Results publications

PMID 19741062, PMID 20047905, PMID 23537968, PMID 26315743, PMID 27913777, PMID 29211671, PMID 30025734, PMID 30586751, PMID 30699446, PMID 31354089, PMID 31592728, PMID 31843251, PMID 33445952, PMID 39968829

NIH funding

2016 (1), U01HL088476 (1)